The inhibition of the TLR4/NF-κB pathway has the potential to impede the differentiation and maturation of osteoclasts, as well as regulate osteoblast differentiation, thereby mitigating the development of osteoporosis (54). The gene discussed is NFKB1; the disease is osteoporosis.